NANOPARTICLES IN H1N1 SWINE FLU VIRUS VACCINE????

The article that has been associated with the claim on nanoparticles in the H1N1 Swine Flu vaccine can be tracked to F. William Engdahl at Global Research. He claimed on September 14: “Vaccines which have been approved by government authorities for vaccination against the alleged H1N1 Influenza A Swine Flu have been found to contain nano particles. Vaccine makers have been experimenting with nanoparticles as a way to “turbo charge” vaccines for several years. Now it has come out that the vaccines approved for use in Germany and other European countries contain nanoparticles in a form that reportedly attacks healthy cells and can be deadly.”

FIRST, Engdahl's claim alleges this vaccine may have been approved for use in Europe. Its role, if any, in America is very unclear.

SECOND, the vast bulk of the reportage claiming that nanoparticles are in the new vaccine is directly traceable to this single individual. Engdahl is a well-known fear monger and author of Full Spectrum Dominance: Totalitarian Democracy in the New World Order. If you want to learn more about him visit his website.

THIRD, his evidence is drawn from the EPFL publication that describes research rather than production. Bioengineering researchers from the EPFL in Lausanne, Switzerland, have developed and patented a nanoparticle that can deliver vaccines more effectively, presumably with fewer side effects, and at a fraction of the cost of current vaccine technologies. This research is reported in a recent issue of Nature Biotechnology.

It is important to note that many research teams are engaged in research of this type. For example, researchers at Oregon State believe lecithin nanoparticles have wide potential applications and possibly a good safety profile. Their findings were just published in the Journal of Controlled Release in work supported by the National Institute of Allergy and Infectious Diseases. In addition, some companies have made claims associated with hypothetical applications of nanoparticles. According to a presentation by BioSante Pharma at the recent Immunotherapeutics & Vaccine Summit, the presenter claimed BioSante’s vaccine adjuvant, BioVant™, increased the protective effect of vaccines for multiple flu strains, including a potential new vaccine against H1N1 (swine flu). Allegedly, BioVant involves calcium nanoparticles.

As to the vaccine, even FOX News reported: "They’re pushing it as fast as they can, but they still have to meet good manufacturing standards," said Dr. Peter Gross, senior vice president and chief medical officer at Hackensack University Medical Center. "It will be tested to make sure it’s safe and contains the proper amounts of protective antibodies," said Gross, who tested flu vaccines for 20 years for the U.S. Food and Drug Administration.